PH21232A - Benzoxazoles and benzothiazoles - Google Patents
Benzoxazoles and benzothiazolesInfo
- Publication number
- PH21232A PH21232A PH25242A PH25242A PH21232A PH 21232 A PH21232 A PH 21232A PH 25242 A PH25242 A PH 25242A PH 25242 A PH25242 A PH 25242A PH 21232 A PH21232 A PH 21232A
- Authority
- PH
- Philippines
- Prior art keywords
- carbon atoms
- substituted
- group
- general formula
- hydrogen atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Polymerisation Methods In General (AREA)
- Eyeglasses (AREA)
- Macromonomer-Based Addition Polymer (AREA)
Abstract
1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL Benzoxazoles of general formula see diagramm : EP0034743,P9,F2 in which R1 represents a hydrogen atom ; a straight or branched alkyl group with 1 to 7 carbon atoms which can be substituted by an alkoxy group with 1 to 3 carbon atoms ; a cycloalkyl group with 3 to 7 carbon atoms ; an alkyl group with 1 to 3 carbon atoms substituted by a phenyl group which can be substituted by one or two alkoxy groups with 1 to 3 carbon atoms ; or a phenyl group which can be substituted by an alkyl or alkoxy group each with 1 to 3 carbon atoms, by a trifluormethyl, nitro or cyano group or by a fluorine, chlorine or bromine atom ; and in addition one of the mono-substituted phenyl groups mentioned above can be substituted by one or two alkyl groups with 1 to 3 carbon atoms or by an alkoxy group with 1 to 3 carbon atoms or by a fluorine, chlorine or bromine atom ; and R2 represents a hydrogen atom or an alkyl group with 1 to 3 carbon atoms ; and their optically active antipodes as well as their physiologically compatible acid addition salts with inorganic or organic acids. 1. Claims for the Contracting State : AT Process for producing benzoxazoles of general formula see diagramm : EP0034743,P10,F4 in which R1 represents a hydrogen atom ; a straight or branched alkyl group with 1 to 7 carbon atoms which can be substituted by an alkoxy group with 1 to 3 carbon atoms ; a cycloalkyl group with 3 to 7 carbon atoms ; an alkyl group with 1 to 3 carbon atoms substituted by a phenyl group which can be substituted by one or two alkoxy groups with 1 to 3 carbon atoms ; or a phenyl group which can be substituted by an alkyl or alkoxy group each with 1 to 3 carbon atoms, by a trifluormethyl, nitro or cyano group or by a fluorine, chlorine or bromine atom ; and additionally one of the mono-substituted phenyl groups mentioned above can be substituted by one or two alkyl groups with 1 to 3 carbon atoms or by an alkoxy group with 1 to 3 carbon atoms or by a fluorine, chlorine or bromine atom ; and R2 represents a hydrogen atom or an alkyl group with 1 to 3 carbon atoms ; and their optically active antipodes as well as their physiologically compatible acid addition salts with inorganic or organic acids characterised in that see diagramm : EP0034743,P11,F1 in which R1 and R2 are as defined in the introduction, X represents a mercapto, alkylmercapto, arylmercapto or aralkylmercapto group, and Y represents a hydrogen atom or an acyl radical, is cyclised ; or b) a carboxylic acid of general formula see diagramm : EP0034743,P11,F3 in which R1 and R2 are as defined in the introduction, or its amides, esters, thioester or halides, is reacted with hydrazine ; and if desired a compound of general formula I, in which R1 represents a hydrogen atom, obtained according to processes a) or b) is subsequently converted by means of alkylation into a corresponding compound of general formula I, in which R1 is defined as in the introduction with the exception of the hydrogen atom and the phenyl radicals mentioned in the introduction, and/or a racemate obtained, of general formula I, is separated by means of racemate separation into its optically active antipodes, and/or a compound obtained, of general formula I, is converted into its physiologically compatible acid addition salts with inorganic or organic acids.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19803006671 DE3006671A1 (en) | 1980-02-22 | 1980-02-22 | NEW BENZOXAZOLES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH21232A true PH21232A (en) | 1987-08-21 |
Family
ID=6095308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH25242A PH21232A (en) | 1980-02-22 | 1981-02-20 | Benzoxazoles and benzothiazoles |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0034743B1 (en) |
| JP (1) | JPS56131581A (en) |
| AT (1) | ATE7696T1 (en) |
| AU (1) | AU543524B2 (en) |
| CA (1) | CA1166252A (en) |
| DE (2) | DE3006671A1 (en) |
| DK (1) | DK151018C (en) |
| ES (3) | ES8206519A1 (en) |
| FI (1) | FI73426C (en) |
| GR (1) | GR74154B (en) |
| HK (1) | HK50785A (en) |
| IE (1) | IE51012B1 (en) |
| IL (1) | IL62181A (en) |
| NO (1) | NO157895C (en) |
| NZ (1) | NZ196313A (en) |
| PH (1) | PH21232A (en) |
| PT (1) | PT72546B (en) |
| SG (1) | SG885G (en) |
| ZA (1) | ZA811130B (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1199027A (en) * | 1981-11-12 | 1986-01-07 | Stuart D. Mills | Heterocyclic derivatives of pyridazinone, thiadiazinone, oxadiazinone and triazinone |
| WO1996025157A1 (en) | 1995-02-17 | 1996-08-22 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
| US6262113B1 (en) | 1996-03-20 | 2001-07-17 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| US6211373B1 (en) | 1996-03-20 | 2001-04-03 | Smithkline Beecham Corporation | Phenyl urea antagonists of the IL-8 receptor |
| TR199802694T2 (en) * | 1996-06-27 | 1999-03-22 | Smithkline Beecham Corporation | IL-8 resept�r kar��tlar� |
| TR199802695T2 (en) | 1996-06-27 | 1999-04-21 | Smithkline Beecham Corporation | IL-8 Resett�r kar��tlar� |
| UY32138A (en) | 2008-09-25 | 2010-04-30 | Boehringer Ingelheim Int | SUBSTITUTED AMIDES 2- (2,6-DICLORO-PHENYLAMINE) -6-FLUORO-1-METHYL-1H-BENCIMIDAZOL-5-CARBOXYL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS |
| UY32470A (en) | 2009-03-05 | 2010-10-29 | Boehringer Ingelheim Int | DERIVATIVES OF 2- {2-CHLORINE-5 - [(REPLACED) METHYL] PHENYLAMINE} -1-METHYL] PHENYLAMINE} -1-METHYLBENCIMIDAZOL-5-CARBOXAMIDES-N- (SUBSTITUTED) AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS, COMPOSITIONS AND APPLIANCE |
| US8586604B2 (en) | 2010-08-20 | 2013-11-19 | Boehringer Ingelheim International Gmbh | Inhibitors of the microsomal prostaglandin E2 synthase-1 |
| US8759537B2 (en) | 2010-08-20 | 2014-06-24 | Boehringer Ingelheim International Gmbh | 3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents |
| US8486968B2 (en) | 2010-12-10 | 2013-07-16 | Boehringer Ingelheim International Gmbh | Compounds |
| US8466186B2 (en) | 2010-12-10 | 2013-06-18 | Boehringer Ingelheim International Gmbh | Compounds |
| UY33779A (en) | 2010-12-10 | 2012-07-31 | Boehringer Ingelheim Int | ? 2- (Phenylamino) -1H-benzimidazol-5-carboxamides novel? |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2516040C2 (en) * | 1974-06-10 | 1984-12-20 | Dr. Karl Thomae Gmbh, 7950 Biberach | Benzimidazoles, processes for their preparation and pharmaceuticals containing them |
| DE2436279A1 (en) * | 1974-07-27 | 1976-02-12 | Henkel & Cie Gmbh | Imidazoline and tetrahydropyrimidine derivs - prepd e.g. by reacting 2-cyano-benzoxazoles with alkylene diamines |
-
1980
- 1980-02-22 DE DE19803006671 patent/DE3006671A1/en not_active Withdrawn
-
1981
- 1981-02-09 EP EP81100890A patent/EP0034743B1/en not_active Expired
- 1981-02-09 DE DE8181100890T patent/DE3163797D1/en not_active Expired
- 1981-02-09 AT AT81100890T patent/ATE7696T1/en active
- 1981-02-12 ES ES499378A patent/ES8206519A1/en not_active Expired
- 1981-02-19 DK DK073781A patent/DK151018C/en not_active IP Right Cessation
- 1981-02-19 GR GR64191A patent/GR74154B/el unknown
- 1981-02-20 FI FI810535A patent/FI73426C/en not_active IP Right Cessation
- 1981-02-20 IL IL62181A patent/IL62181A/en unknown
- 1981-02-20 JP JP2323281A patent/JPS56131581A/en active Granted
- 1981-02-20 IE IE343/81A patent/IE51012B1/en not_active IP Right Cessation
- 1981-02-20 PH PH25242A patent/PH21232A/en unknown
- 1981-02-20 AU AU67519/81A patent/AU543524B2/en not_active Ceased
- 1981-02-20 ZA ZA00811130A patent/ZA811130B/en unknown
- 1981-02-20 NO NO810586A patent/NO157895C/en unknown
- 1981-02-20 CA CA000371339A patent/CA1166252A/en not_active Expired
- 1981-02-20 PT PT72546A patent/PT72546B/en not_active IP Right Cessation
- 1981-02-20 NZ NZ196313A patent/NZ196313A/en unknown
-
1982
- 1982-02-12 ES ES509533A patent/ES8302700A1/en not_active Expired
- 1982-02-12 ES ES509532A patent/ES509532A0/en active Granted
-
1985
- 1985-01-04 SG SG8/85A patent/SG885G/en unknown
- 1985-07-04 HK HK507/85A patent/HK50785A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO810586L (en) | 1981-08-24 |
| AU543524B2 (en) | 1985-04-26 |
| IL62181A0 (en) | 1981-03-31 |
| EP0034743B1 (en) | 1984-05-30 |
| SG885G (en) | 1985-11-15 |
| IL62181A (en) | 1984-10-31 |
| PT72546A (en) | 1981-03-01 |
| EP0034743A1 (en) | 1981-09-02 |
| IE810343L (en) | 1981-08-22 |
| ES8302699A1 (en) | 1983-01-16 |
| ES509532A0 (en) | 1983-01-16 |
| NO157895C (en) | 1988-06-08 |
| JPS6334154B2 (en) | 1988-07-08 |
| DE3163797D1 (en) | 1984-07-05 |
| NZ196313A (en) | 1984-07-06 |
| GR74154B (en) | 1984-06-06 |
| DE3006671A1 (en) | 1981-08-27 |
| ES509533A0 (en) | 1983-01-16 |
| PT72546B (en) | 1982-10-21 |
| JPS56131581A (en) | 1981-10-15 |
| DK73781A (en) | 1981-08-23 |
| ES499378A0 (en) | 1982-08-16 |
| HK50785A (en) | 1985-07-12 |
| IE51012B1 (en) | 1986-09-03 |
| ATE7696T1 (en) | 1984-06-15 |
| CA1166252A (en) | 1984-04-24 |
| NO157895B (en) | 1988-02-29 |
| ES8206519A1 (en) | 1982-08-16 |
| AU6751981A (en) | 1981-08-27 |
| FI73426B (en) | 1987-06-30 |
| DK151018C (en) | 1988-06-20 |
| DK151018B (en) | 1987-10-12 |
| ZA811130B (en) | 1982-10-27 |
| ES8302700A1 (en) | 1983-01-16 |
| FI73426C (en) | 1987-10-09 |
| FI810535L (en) | 1981-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU543524B2 (en) | Benzoxazoles and benzothiazoles | |
| HUT34193A (en) | Process for the production of substituted 6-aryl-1,2,4-triazolo/4,3-b/-pyridazin-derivatives and of pharmaceutic products containing such compounds | |
| DE3169210D1 (en) | Substituted azolyl-glycolsulfonates, fungicides containing them and process for their preparation | |
| DE3061105D1 (en) | Pyrazolin-5-on-yl-methyl-(di)thiophosphoric acid esters, process for their preparation and their use as pesticides | |
| EG15833A (en) | Hemiorthoamide intermediates for production of benzothiazine carboxamides | |
| DK161599C (en) | METHOD OF PREPARING LYRIC ACID EASTERS |